Literature DB >> 1393291

The influence of endothelin-1 on human foeto-placental blood vessels: a comparison with 5-hydroxytryptamine.

M R MacLean1, A G Templeton, J C McGrath.   

Abstract

1. The vasoconstrictor effect of endothelin-1 (3 x 10(-11) M-10(-7) M) was studied in successive generations of blood vessels of the foeto-placental vascular tree. These were the human umbilical arteries and veins, primary surface chorionic plate arteries, secondary chorionic plate arteries, tertiary surface chorionic plate arteries and veins and the secondary stem villus arterioles. The responses to endothelin-1 were compared with those to 5-hydroxytryptamine (10(-9) M-10(-5) M). Arterial preparations were gassed with 2.5% O2, 8% CO2 balance N2 and venous preparations were gassed with 5% O2, 6% CO2 balance N2 to simulate the conditions prevalent in utero. The influence of increasing the oxygen tension to 16% (that prevalent at birth) on the response to endothelin-1 on the umbilical arteries was also investigated. 2. All the arterial vessels tested were some ten times more sensitive to endothelin-1 than to 5-hydroxytryptamine and the venous preparations were ten times more sensitive to endothelin-1 than were their equivalent arteries. Increasing oxygen tension did not affect the responses to endothelin-1 in the umbilical artery. 3. Whilst the amplitude of the endothelin-1-induced response was uniform throughout the foetoplacental vascular tree, including the stem villus arterioles, the maximum response to 5-hydroxytryptamine decrease with successive generations and it had no significant effect on the stem villus arterioles.The ratios of the responses to 10- M endothelin-1: 10-7M 5-hydroxytryptamine in human umbilical arteries, primary surface chorionic plate arteries, secondary chorionic plate arteries,tertiary surface chorionic plate arteries and the secondary stem villus arterioles in the vessels (listed in order of decreasing vessel size) were 1:1.2, 1:0.36, 1:0.33, 1:0.35 and 1:0.04 respectively.4. In conclusion, endothelin-1 is a powerful vasoconstrictor at all levels of the foeto-placental vascular system including the stem villus resistance vessels. It may play an important role in maintaining foeto-plancental vascular resistance at the low oxygen tension which exists in this vascular system in utero.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393291      PMCID: PMC1907685          DOI: 10.1111/j.1476-5381.1992.tb14438.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Mechanical properties of vascular smooth muscle cells in situ.

Authors:  M J Mulvany; W Halpern
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

2.  Increased plasma endothelin level in patients with essential hypertension.

Authors:  Y Saito; K Nakao; M Mukoyama; H Imura
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

3.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Mechanism of endothelin-1-induced pulmonary vasoconstriction.

Authors:  M J Horgan; J M Pinheiro; A B Malik
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

6.  Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells.

Authors:  M Kohno; K Yasunari; K Yokokawa; K Murakawa; T Horio; Y Kanayama; M Fuzisawa; T Inoue; T Takeda
Journal:  Metabolism       Date:  1990-10       Impact factor: 8.694

7.  Human cultured endothelial cells do secrete endothelin-1.

Authors:  M Clozel; W Fischli
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

8.  Increased maternal plasma concentration of endothelin-1 during labor pain or on delivery and the existence of a large amount of endothelin-1 in amniotic fluid.

Authors:  S Usuki; T Saitoh; T Sawamura; N Suzuki; S Shigemitsu; M Yanagisawa; K Goto; H Onda; M Fujino; T Masaki
Journal:  Gynecol Endocrinol       Date:  1990-06       Impact factor: 2.260

9.  Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed.

Authors:  S A Douglas; S James; C R Hiley
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery.

Authors:  A G Templeton; J C McGrath; M J Whittle
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

View more
  5 in total

1.  Differential localization of endothelin ETA and ETB binding sites in human placenta.

Authors:  R A Rutherford; J Wharton; A McCarthy; L Gordon; M H Sullivan; M G Elder; J M Polak
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

2.  Mechanical and biochemical responses to endothelin-1 and endothelin-3 in bovine bronchial smooth muscle.

Authors:  J E Nally; R McCall; L C Young; M J Wakelam; N C Thomson; J C McGrath
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

3.  Colocalization of vasoactive substances in the endothelial cells of human umbilical vessels.

Authors:  W Q Cai; K Dikranian; P Bodin; M Turmaine; G Burnstock
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

4.  Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteries.

Authors:  S Sabry; F Mondon; M Levy; F Ferré; A T Dinh-Xuan
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

5.  Endothelin receptors mediating functional responses in human small arteries and veins.

Authors:  J Riezebos; I S Watts; P J Vallance
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.